Form 4: InfuSystem CEO Carrie Lachance Receives Equity Grant
Statement of Changes in Beneficial Ownership
InfuSystem Holdings, Inc. CEO Carrie Lachance was granted stock options and restricted stock units as part of an equity compensation package.
Summary
- CEO Carrie Lachance received a grant of 62,117 stock options with an exercise price of $8.37.
- The CEO also received 29,816 restricted stock units (RSUs).
- The stock options vest in four equal annual installments starting May 12, 2027.
- The RSUs vest in three equal annual installments starting May 12, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is a routine corporate event.
Positives
- Equity-based compensation aligns the interests of the CEO with those of shareholders.
- The multi-year vesting schedule encourages long-term retention of executive leadership.
Negatives
- The issuance of new equity awards results in potential future dilution for existing shareholders.
Risks
- Future share price volatility could impact the ultimate value realized by the executive from these grants.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a disclosure of executive equity compensation.
Industry Context
StockSavvy.ai notes that equity grants for executive leadership are standard corporate governance practices intended to incentivize long-term performance and align management with shareholder value creation.
Comparison to Industry Standards
- The use of multi-year vesting schedules for executive equity is consistent with standard compensation practices for publicly traded healthcare and medical device companies.
- The mix of stock options and RSUs is a common structure used to balance performance incentives with retention.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise or vesting of these equity instruments.
Next Steps
- Vesting of initial tranches of equity on May 12, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/12/2026 | Date of grant for stock options and restricted stock units. |
| 05/12/2027 | Initial vesting date for both stock options and restricted stock units. |
| 05/12/2029 | Final vesting date for restricted stock units. |
| 05/12/2036 | Expiration date for stock options. |
Keywords
InfuSystem, INFU, Form 4, Executive Compensation, Insider Trading, Stock Options, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.